Does Rallies show 13F holders for TMO?

Yes. Rallies tracks hedge fund and 13F ownership data for TMO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TMO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.

TMO (Thermo Fisher) Stock Analysis - Hedge Fund Holdings

Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of May 20, 2026, TMO trades at $449.99 with a market cap of $164.26B and a P/E ratio of 24.62. TMO moved +0.93% today. Year to date, TMO is -24.42%; over the trailing twelve months it is +8.19%. Its 52-week range spans $385.46 to $643.99. Analyst consensus is strong buy with an average price target of $611.60. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TMO stock?

Hedge funds tracked by Rallies that own TMO include Viking Global, TCI Fund, Temasek Holdings, Farallon Capital, and D1 Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Thermo Fisher.

TMO Key Metrics

Key financial metrics for TMO
Metric	Value
Price	$449.99
Market Cap	$164.26B
P/E Ratio	24.62
EPS	$18.22
Dividend Yield	0.47%
52-Week High	$643.99
52-Week Low	$385.46
Volume	2.42M
Avg Volume	0
Revenue (TTM)	$45.20B
Net Income	$6.87B
Gross Margin	0.00%

Top Hedge Funds Holding TMO

Viking Global holds 1.67M shares of TMO, changed +110.29% as of Mar 31, 2026.
TCI Fund holds 1.52M shares of TMO, changed -51.77% as of Mar 31, 2024.
Temasek Holdings holds 1.20M shares of TMO, changed +34.15% as of Mar 31, 2026.
Farallon Capital holds 881.49K shares of TMO, changed +38.67% as of Mar 31, 2026.
D1 Capital holds 725.00K shares of TMO, changed +0.00% as of Mar 31, 2026.

Latest TMO News

Thermo Fisher Q1 Revenue Hits $11.01B, EPS Beats Estimates, Flags Inflation Risk — Apr 23, 2026
Thermo Fisher slides as Q1 organic growth stays muted despite reported revenue gain — Apr 23, 2026
Thermo Fisher Q1 Revenue Rises 6% to $11.01B; EPS Up and $3B Buyback — Apr 23, 2026
Thermo Fisher slides as price-target cut revives growth worries after Clario deal close — Apr 16, 2026
Thermo Fisher jumps as Clario deal momentum builds ahead of April 23 earnings — Apr 14, 2026

Recent TMO Insider Trades

Pettiti Gianluca sold 400 (~$185.06K) on Apr 27, 2026.
Shafer Michael D sold 1.61K (~$802.54K) on Mar 11, 2026.
CASPER MARC N sold 20 (~$10.07K) on Mar 5, 2026.

TMO Analyst Consensus

17 analysts cover TMO: 0 strong buy, 15 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $611.60.

Common questions about TMO

Who owns TMO stock?: Hedge funds tracked by Rallies that own TMO include Viking Global, TCI Fund, Temasek Holdings, Farallon Capital, and D1 Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Thermo Fisher.
Does Rallies show 13F holders for TMO?: Yes. Rallies tracks hedge fund and 13F ownership data for TMO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TMO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.